FilingReader Intelligence
Fosun Pharma continues A-share and H-share repurchase programs
June 3, 2025 at 05:09 PM UTC•By FilingReader AI
Shanghai Fosun Pharmaceutical Group (SSE:600196) announced the progress of its ongoing A-share and H-share repurchase programs, with no A-share repurchases in May. As of May 31, 2025, the company had cumulatively repurchased 7,310,552 A-shares, representing approximately 0.2738% of the total share capital, for approximately CNY 17,497.88 million. The highest and lowest prices for A-share repurchases were CNY 25.39 and CNY 23.34 per share, respectively.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
SSE:600196•Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime